Acuson and ATL settle patent dispute
Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled
Acuson and Advanced Technology Laboratories last week settleda patent dispute between the ultrasound competitors relating tomultiplane transesophageal (TEE) technology and an ultrasoundfocusing technique. The settlement ends lawsuits that had beenfiled last year in federal courts in Washington and California.
ATL had claimed that Acuson was infringing on its TEE patents,while Acuson charged ATL will violating its patent for an ultrasoniclens with reduced delay range. As part of the settlement, Acusonagreed to pay ATL an undisclosed sum in royalty payments on TEEprobes it sells. The companies entered a cross-licensing agreementfor several patents, including the Acuson focusing patent.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study: Black Patients Less Likely Than Others to Receive MRI Assessment of Cognitive Impairment
November 27th 2023In a four-year study of over 1,600 patients who had outpatient head CTs, head CT angiography and/or brain MRI to assess cognitive impairment, researchers found that Black patients were over 9 percent less likely than White patients and over 16 percent less likely than Hispanic patients to receive brain MRI.
